| HOME >> BIOLOGY >> TECHNOLOGY |
Dr. Daniel Weiner Will Discuss Challenges and Opportunities to Realize
Critical Path Initiative Goals
MOUNTAIN VIEW, Calif., Oct. 11 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Daniel Weiner, Ph.D., senior vice president and chief technology officer, has been invited to speak to U.S. and Japanese biopharmaceutical executives attending a session on research and development productivity hosted by the New York Pharma Forum (NYPF), to be held in New York City, October 15, 2007.
Dr. Weiner's presentation will discuss the technical, organizational and process changes needed to reach the goals of the FDA's Critical Path Initiative for improving drug development productivity, including opportunities for the adoption of quantitative drug-disease modeling and simulation. Dr. Weiner will join other industry experts as part of the NYPF program entitled "R&D Productivity: Are There Winning Strategies?" The session will also offer a forum for interdisciplinary discussion on areas of opportunity in the drug development and approval process.
"Pharsight has built a strong reputation for providing critical
solutions that increase productivity in the drug development industry,"
said Shawn O'Connor, president, chief executive officer, and chairman of
Pharsight. "Through our strategic consulting services and growing family of
software products, we have successfully collaborated with global drug
developers to incorporate modeling and simulation into their development
processes. These collaborations have yielded a number of success stories,
ranging from increased efficiencies and more confident decision-making to
better resource management. Pharsight is pleased to participate at this
NYPF event, and to offer its perspectives on opportunities, challenges and
supporting t
'/>"/>
| SOURCE Pharsight Corporation Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Why companies dont get invited to the DEMO conference
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |